Acylin is the first biotechnology company focused on developing inhibitors of cellular acylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease and neurodegeneration.
Acquired in 2014
Alder’s mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. As a licensing partner, Alder is also revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics.
Initial Public Offering (NASDAQ: ALDR) in May 2014
Amnis is developing high-throughput laboratory automation tools that use a novel molecule detection technology. The Amnis platform has both molecular and cellular-based applications in research and the clinic.
Acquired by EMD Millipore, the Life Science division of Merck KGaA, in August 2011
AnswerDash was born out of four years of scientific research at the University of Washington into how people interact with websites, both desktop and mobile. That research revealed that people are regularly confused online, and when they are, they prefer to simply select items they have questions about, rather than describing their problems in text (as required by email, live chat, forums, or searchable knowledgebases). AnswerDash's mission is to reduce site abandonment by providing selection-based answers online, right where people need them. No typing. No digging. No leaving the page. Simply click or tap to get an answer. Easy and effective.
Acquired by CloudEngage in June 2020
Bellwether Bio is a privately-held Seattle-based startup developing novel cell-free DNA-based diagnostic technologies.
Acquired by Guardant Health in April 2019
Corus Pharma develops pharmaceutical products that address unmet needs in infectious disease and respiratory disorders.
Acquired by Gilead Sciences, Inc. in August 2006
C-SATS is a performance management system for evaluating and improving technique in healthcare professionals rapidly, accurately and cost effectively.
Acquired by Johnson & Johnson in April 2018
Decide's e-commerce service finds the lowest prices for a vast range of consumer electronics and offers predictions on new model releases and future price changes.
Acquired by eBay in September 2013
Next Generation Energy Storage
Acquired by BASF in June 2016
EKOS is developing technologies that use localized ultrasound to facilitate, enhance or control the delivery or activation of drugs at a targeted tissue site.
Acquired by BTG in May 2013
This University of Washington startup uses a combination of techniques to find patterns in the variation of airline ticket prices over time and so predict future price movements. The method may also apply to hotel rooms, rental cars and other analogous markets.
Acquired by Microsoft in April 2008
FlexMinder delivers Software as a Service (SaaS) that saves consumers time and money while reducing costs for TPAs, private health exchanges and health carriers. FlexMinder simplifies the consumer experience by aggregating an individual's healthcare information from multiple sources and automating the reimbursement process for their FSA healthcare claims.
Acquired by Jellyvision in January 2017
GlobeImmune is a biopharmaceutical company developing targeted molecular immunogens (Tarmogens) for the treatment of cancer and infectious diseases.
Initial Public Offering (NASDAQ: GBIM) in July 2014
HaloSource, Inc. is a bioscience company that employs chitin/chitosan and N-halamine-based technologies to serve the water treatment, biomedical, home and personal care markets.
Initial Public Offering (LSE: HALO.L) in October 2010
As a fully integrated biotherapeutics company, Ikaria is positioned to help advance critical care. Leveraging a combination of highly specialized insight into human biology, clinical expertise, an intimate understanding of clinical needs and an intense level of caring allows Ikaria to achieve remarkable goals.
Acquired by Mallinckrodt in March 2015
Intelligent Ion is developing a miniature mass spectrometer based on proprietary technologies developed at the University of Washington and California Institute of Technology/Jet Propulsion Laboratory.
Assets and intellectual property were acquired by O.I. Corp. in December 2004
Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Initial Public Offering (NASDAQ: JUNO) in December 2014
Lumera develops electro-photonic components based on proprietary polymer materials licensed from the University of Washington.
Initial Public Offering (NasdaqNM: LMRA) in 2004
Mirador Biomedical is developing disposable medical devices that provide data to physicians during common medical procedures to eliminate preventable complications and make the procedures safer.
Acquired by Centurion Medical Products in October 2014
Mobisante, Inc. is a privately held mHealth product and services company. Their goal is to make ultrasound imaging more affordable and accessible to help health care professionals practice better medicine and to reduce costs.
Acquired by Renew Group in November 2015
Nimbic (formerly Physware) helps customers solve their signal integrity (SI), power integrity (PI) and EMI challenges in a variety of design areas including microprocessors, FPGAs, memory, wireless RF systems, analog systems, and high-speed serial and parallel channels.
Acquired by Mentor Graphics Corp. in May 2014
nLIGHT is a leading supplier of high-power semiconductor-based lasers for microelectronics, material processing, defense and medical applications. nLIGHT develops and manufactures fiber lasers, diode-pumped solid-state lasers and direct-diode lasers.
Initial Public Offering (Nasdaq: LASR) in April 2018
Numinous Technologies was founded in 1996 to develop graphics and interactive video software. Among its founders are noted computer graphics scientists David Salesin of the University of Washington and Andries van Dam of Brown University.
Acquired by Microsoft in March 1999
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Initial Public Offering (NasdaqNM: OMER) in October 2009
Pacific Bioscience Laboratories, Inc., a Washington company incorporated in 2001, is the developer of the Clarisonic™ Skin Care System, a range of devices that use sonic waves to enable users to achieve healthier, younger-looking skin.
Acquired by L’Oréal in December 2011
Pathway Medical Technologies, Inc. was founded to develop, manufacture and market medical devices for the treatment of arterial disease. The company’s initial focus is treating peripheral arterial disease (PAD) more quickly, safely and effectively than existing technologies.
Acquired by MEDRAD, Inc., an affiliate of Bayer HealthCare, in August 2011
Performant is developing leading-edge technology to optimize back-end performance of enterprise computer systems. The company’s OptiBench product suite will enable customers to completely outsource the management of their information technology system’s performance.
Acquired by Mercury Interactive in May 2003
RBL is developing standards-based educational curriculum and assessment tools delivered through the internet. The RBL software is based on 35 years of study by Norris Haring, a founding director of the EEU Center on Human Development and Disability at the University of Washington.
Acquired by McGraw-Hill Education in April 2002
Shippable is a cloud platform that gives developers a seamless way to add continuous integration and deployment to GitHub projects. It takes less than a minute to set up and requires no maintenance. You sign in with your GitHub credentials, add a config file, create a job, and voila - we will run your builds and tests for every code commit. Our goal is to let you focus on coding, and leave the integrating and deploying to us.
Acquired by JFrog in February 2019
SNUPI Technologies is a sensor and services company focused on home safety, security, and loss prevention. Our customers use our devices, in connection with our monitoring service, to discover and alert themselves when a hazardous event occurs in their home. SNUPI (Sensor Network Utilizing Powerline Infrastructure) technology is an ultra-low-power, general-purpose wireless sensing platform that is easily used and maintained by leveraging the existing electrical wiring as a whole home antenna.
WallyHome technology acquired by Sears Holdings Corp. in October 2015
Uptake Medical is developing a novel, minimally invasive lung volume reduction technology for patients suffering from emphysema and other types of chronic obstructive pulmonary diseases (COPD).
Acquired by Broncus Holding Company in August 2016
Washington Research Foundation values diversity. We're committed to diversity, equity and inclusion in our staff, our board of directors, and the researchers, entrepreneurs and organizations we fund. We encourage people of color, women and other underserved communities to apply for our employment, grant-making and investment opportunities.
© 2020 Washington Research Foundation, Seattle WA (206) 336-5600